Examining the adequacy of quantities available for subsidized antidepressant prescriptions in Australia

Pharmacoepidemiology and Drug Safety

Volumn 8, Issue 3, 1999, Pages 191-195

  McManus, Peter ^a   Mant, Andrea ^b   Birkett, Don ^c   Hemming, Mary ^d   Lindner, Julie ^a  

^a Canberra ACT   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d Therapeutic Guidelines Limited   (Australia)

Author keywords

Antidepressants; Defined daily dose; Drug utilization; Pharmacoepidemiology; Prescription

Indexed keywords

ANTIDEPRESSANT AGENT; MOCLOBEMIDE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; AUSTRALIA; DEPRESSION; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE;

EID: 0033021313     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199905/06)8:3<191::AID-PDS417>3.0.CO;2-X     Document Type: Article

References (6)

1. Nordic Council on Medicines. Nordic Statistics on Medicines 1990-1992, NLN publication number 34, Nordic Council On Medicines, Uppsala, 1993.
2. Edmonds, D. J., Dumbrell, D. M., Primrose, J. G., McManus, P., Birkett, D. J. and Demirian, V. Development of an Australian drug utilisation database: a report from the Drug Utilization Sub-committee of the Pharmaceutical Benefits Advisory Committee. Pharmaco Economics 1993; 3(6): 427-432.
3. Moore, M. V. More on what is an effective dose. Br. Med. J. 1997; 314: 826.
4. Winfield, S. Antidepressants as hypnotics. Aust. N.Z. J. Psychiatr. 1989; 23(3): 313.
5. Tan, R. S. Low dose tricyclic antidepressants are effective in treating major depression. Br. Med. J. 1997; 314: 827.
6. Psychotropic Guidelines Sub-Committee of the Victoria Drug Usage Advisory Committee. Psychotropic Guidelines, 3rd edn, Victorian Postgraduate Medical Foundation, Melbourne, 1995.